What Rockwell Medical Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 4 |
| Total trades | 1 | 20 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 16,317 |
| Disposed | 1,000 | 3,717 |
| Net activity | −1,000 | +12,600 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Strobeck Mark | President and CEO | Oct 01 | Open-market sale · S | −1,000 | $8.42 | −$8.42K | 61,349 |
| Strobeck Mark | President and CEO | Jul 01 | Grant / award · A | +30,000 | — | — | 62,349 |
| Neri Jesse | SVP and CFO | Jul 01 | Grant / award · A | +15,000 | — | — | 27,239 |
| Timmins Megan C. | EVP, CLO & Secretary | Jul 01 | Grant / award · A | +15,000 | — | — | 31,240 |
| Hunter Heather | Chief Operating Officer | Jul 01 | Grant / award · A | +15,000 | — | — | 28,007 |
| Chole Timothy | SVP and CCO | Jul 01 | Grant / award · A | +15,000 | — | — | 27,285 |
| Cooper John G | Director | Jul 01 | Grant / award · A | +9,633 | — | — | 23,670 |
| Radie Robert S | Director | Jul 01 | Grant / award · A | +9,633 | — | — | 23,985 |
| Lau Joan | Director | Jul 01 | Grant / award · A | +9,633 | — | — | 20,944 |
| Nissenson Allen | Director | Jul 01 | Grant / award · A | +9,633 | — | — | 23,892 |
| Dawson Joseph H | Director | Jul 01 | Grant / award · A | +9,633 | — | — | 12,133 |
| Chole Timothy | SVP and CCO | Mar 14 | Withheld — tax / exercise cost · F | −2,444 | $0.90 | −$2.2K | 122,855 |
| Strobeck Mark | President and CEO | Mar 14 | Withheld — tax / exercise cost · F | −7,333 | $0.90 | −$6.6K | 323,493 |
| Neri Jesse | SVP and CFO | Mar 14 | Withheld — tax / exercise cost · F | −2,444 | $0.90 | −$2.2K | 122,398 |
| Timmins Megan C. | See Remarks | Mar 14 | Withheld — tax / exercise cost · F | −3,667 | $0.90 | −$3.3K | 162,408 |
| Hunter Heather | Chief Operating Officer | Mar 14 | Withheld — tax / exercise cost · F | −2,444 | $0.90 | −$2.2K | 130,079 |
| Neri Jesse | SVP and CFO | Jan 02 | Open-market sale · S | −886 | $0.84 | −$740 | 124,842 |
| Hunter Heather | Chief Operating Officer | Jan 02 | Open-market sale · S | −2,868 | $0.84 | −$2.4K | 132,523 |
| Cooper John G | Director | Nov 18 | Open-market sale · S | −5,079 | $0.87 | −$4.42K | 140,372 |
| Dawson Joseph H | Director | Nov 17 | Grant / award · A | +25,000 | — | — | 25,000 |
Loading...
